These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20502131)

  • 1. Lamotrigine administration in panic disorder with agoraphobia.
    Masdrakis VG; Papadimitriou GN; Oulis P
    Clin Neuropharmacol; 2010 May; 33(3):126-8. PubMed ID: 20502131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical picture and treatment of agoraphobia with panic disorder].
    Litvintsev SV; Reznik AM; Kvashnina NV; Arbuzov AL; Krylov KE
    Voen Med Zh; 2003 Jun; 324(6):53-9. PubMed ID: 12916423
    [No Abstract]   [Full Text] [Related]  

  • 3. [Panic disorder and agoraphobia: what is effective?].
    Bandelow B; Sievert K; Röthemeyer M; Hajak G; Broocks A; Rüther E
    Fortschr Neurol Psychiatr; 1995 Nov; 63(11):451-64. PubMed ID: 8575719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpidem in the treatment of panic disorder.
    Schneier FR; Carrasco JL; Hollander E; Campeas R; Fallon B; Saoud JB; Feerick J; Liebowitz MR
    J Clin Psychopharmacol; 1993 Apr; 13(2):150-3. PubMed ID: 8096527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V; Uhlenhuth EH
    Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical implications of agoraphobia in patients with panic disorder.
    Shin J; Park DH; Ryu SH; Ha JH; Kim SM; Jeon HJ
    Medicine (Baltimore); 2020 Jul; 99(30):e21414. PubMed ID: 32791758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
    Spiegel DA; Saeed SA; Bruce TJ
    J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dizziness associated with panic disorder and agoraphobia: case report and literature review.
    Caliman e Gurgel JD; Costa KV; Cutini FN; Sarmento Júnior KM; Mezzasalma MA; Cavalcanti HV
    Braz J Otorhinolaryngol; 2007; 73(4):569-72. PubMed ID: 17923930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lamotrigine and the skin].
    Rätz Bravo AE; Zimmermann T; Haschke M
    Praxis (Bern 1994); 2010 Mar; 99(6):337-45; quiz 344. PubMed ID: 20235021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cognitive-behavioral therapy for comorbid panic disorder with agoraphobia and generalized anxiety disorder.
    Labrecque J; Marchand A; Dugas MJ; Letarte A
    Behav Modif; 2007 Sep; 31(5):616-37. PubMed ID: 17699121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?
    Oei TP; Llamas M; Evans L
    Behav Res Ther; 1997 Sep; 35(9):851-7. PubMed ID: 9299805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia.
    Maddock RJ; Carter CS; Blacker KH; Beitman BD; Krishnan KR; Jefferson JW; Lewis CP; Liebowitz MR
    J Clin Psychiatry; 1993 Mar; 54(3):88-95. PubMed ID: 8468314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gepirone and the treatment of panic disorder: an open study.
    Pecknold JC; Luthe L; Scott-Fleury MH; Jenkins S
    J Clin Psychopharmacol; 1993 Apr; 13(2):145-9. PubMed ID: 8096526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK; Kustra RP; Hammer AE
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial.
    Siegmund A; Golfels F; Finck C; Halisch A; Räth D; Plag J; Ströhle A
    J Psychiatr Res; 2011 Aug; 45(8):1042-7. PubMed ID: 21377691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of medical services and treatment for panic disorder with agoraphobia and for social phobia.
    Swinson RP; Cox BJ; Woszczyna CB
    CMAJ; 1992 Sep; 147(6):878-83. PubMed ID: 1525731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants.
    Toni C; Perugi G; Frare F; Mata B; Vitale B; Mengali F; Recchia M; Serra G; Akiskal HS
    Pharmacopsychiatry; 2000 Jul; 33(4):121-31. PubMed ID: 10958260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure.
    Cox BJ; Endler NS; Lee PS; Swinson RP
    J Behav Ther Exp Psychiatry; 1992 Sep; 23(3):175-82. PubMed ID: 1487535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
    Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
    Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.